Impact of Asthma Treatments on Daily Activities

NCT ID: NCT00350376

Last Updated: 2006-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Allergies

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

asthma allergies Xolair Advair

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have asthma and allergies
* Currently taking Xolair® or Advair®
* Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
* Between 18 and 55 years of age
* A non-smoker for at least 6 months
* Have internet access
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Genentech, Inc.

INDUSTRY

Sponsor Role collaborator

Ovation Research Group

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susan D Mathias, MPH

Role: PRINCIPAL_INVESTIGATOR

Ovation Research Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ovation Research Group

San Francisco, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nita Ngo, MPH

Role: CONTACT

Phone: 888.631.9167

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1467

Identifier Type: -

Identifier Source: org_study_id